Laurent Fischer
2020
In 2020, Laurent Fischer earned a total compensation of $21.3M as President and Chief Executive Officer at Avalanche Biotechnologies.
Compensation breakdown
| Non-Equity Incentive Plan | $267,300 |
|---|---|
| Option Awards | $20,703,000 |
| Salary | $327,308 |
| Other | $1,000 |
| Total | $21,298,608 |
Fischer received $20.7M in option awards, accounting for 97% of the total pay in 2020.
Fischer also received $267.3K in non-equity incentive plan, $327.3K in salary and $1K in other compensation.
Rankings
In 2020, Laurent Fischer's compensation ranked 195th out of 13,090 executives tracked by ExecPay. In other words, Fischer earned more than 98.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 195 out of 13,090 | 99th |
Division Manufacturing | 56 out of 5,617 | 99th |
Major group Chemicals And Allied Products | 14 out of 2,248 | 99th |
Industry group Drugs | 13 out of 1,948 | 99th |
Industry Biological Products, Except Diagnostic Substances | 5 out of 411 | 99th |
Source: SEC filing on April 26, 2022.
Fischer's colleagues
We found three more compensation records of executives who worked with Laurent Fischer at Avalanche Biotechnologies in 2020.